Collaborative Studies and Reporting Back

Date: Saturday 14 May
Time: 08:30 – 16:00

Time Event
09:00 – 12:00 Patient Advocacy and Education – UK, Spain, Germany, USA
08:30 – 10:30 Reporting Back Session
08:30 – 08:45 Registries – Pål Møller
08:45 – 09:00 IMRC – Mark Jenkins
09:00 – 09:15 MMR European Group – Moni Morak, Elke Holinski, Gabriel Capella
09:15 – 09:30 Surgery and Endoscopy – Gabriel Moeslein, others
09:30 – 09:45 Chemoprevention for Polyposis Syndromes – Pat Lynch, others
09:45 – 10:00 VIC: Variant Interpretation Committee – Maurizio Genaurdi, John-Paul Plazzer
10:00 – 10:15 Chemoprevention LS and Immunotherapy – Magnus V Knebel-Doeberitz, John Burn
10:15 – 10:30 To be confirmed
10:30 – 11:00 Coffee Break
11:00 – 12:30  EHTG Open and New Collaborative Studies
11:00 – 11:15 Renal Cell Carcinoma in Lynch Syndrome: a Preliminary Report from a Mallorca Group Collaborative Study – Maurizio Genuardi
11:15 – 11:30 Role of Genetic Modifiers in Disease Risk – Lynch Syndrome – Rodney Scott, Bente Talseth-Palmer
11:30 – 11:45 IMRC – Mark Jenkins
11:45 – 12:00 PLSD: New Goals/Call for Additional Data – Pål Møller
12:00 – 12:30 Reporting Back from Patient Advocacy and Education
12:30 – 13:15 Lunch
13:15 – 16:00 Former Mallorca Group Meeting

 

Top